Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivastigmine for delirium in intensive care patients
2007-005300-41Phase 4Terminated
- Sponsor
- University Medical Center Utrecht
- Start
- Feb 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in delirium comparing Rivastigmine add-on with Placebo add-on (2 arms). Primary endpoint: Duration of delirium during hospital admission. Started Feb 2008; status: terminated.
02
Drugs
rivastigmine
03
Conditions
delirium
Beyond the preview
Go deeper on 2007-005300-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005300-41.